Skip to content

The effect of olive leaf extract and curcumin combination on improvement of clinical signs and symptoms and quality of life in patients with external anogenital wart

The effect of olive leaf extract and curcumin combination on improvement of clinical signs and symptoms and quality of life in patients with external anogenital wart

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20200509047350N1
Enrollment
66
Registered
2020-05-14
Start date
2020-06-21
Completion date
Unknown
Last updated
2020-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Genital Warts. Anogenital (venereal) warts

Interventions

Intervention 1: Intervention group:Routine treatment with pedophile 20% once a week until clinical repair (maximum 12 weeks) and the use of 10% olive leaf extract ointment and 10% curcumin in the amou

Sponsors

Khoram-Abad University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Confirmation and introduction of a midwifery specialist for the patient to enter the study (having external anogenital warts) Age 18 and up No pregnancy or lactation The desire to participate in research and sign a conscious consent Lack of incurable, metabolic and chronic diseases and weakness in the immune system Do not use corticosteroids or antiviral drugs and weaken the immune system during research Lack of pelvic inflammatory disease, other genital infectious diseases Failure to participate in other research that in any way affects the results of the research Phone access

Exclusion criteria

Exclusion criteria: Lack of proper and appropriate use of drugs Lack of desire to continue research Any allergies caused by the drug Disabling the patient or changing the patient's contact number and not answering the phone call Pregnancy Severe type of disease that requires surgery or systemic medication

Design outcomes

Primary

MeasureTime frame
Clinical Signs and Symptoms: In this study, the clinical signs and symptoms of itching, burning, pain, warts and bleeding are considered. Timepoint: Every week and the intervals between visits for a maximum of 12 weeks. Method of measurement: clinical examination, self-report.

Secondary

MeasureTime frame
Quality of Life. Timepoint: The day before treatment, after clinical repair. Method of measurement: Life Quality Questionnaire 36 questions SF36.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactTahereh Toulabi

Khoram-Abad University of Medical Sciences

toulabi_t@yahoo.com+98 66 3330 0661

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 10, 2026